Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03645395
Title PK,PD, Safety and Tolerability of Multiple Dose Regimens of MT-3724 With Lenalidomide for the Treatment of Patients With Relapsed/Refractory Diffuse Large B Cell Non-Hodgkin's Lymphoma (MT-3724_NHL_003)
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors Molecular Templates, Inc.
Indications

diffuse large B-cell lymphoma

B-cell lymphoma

Therapies

Lenalidomide + MT-3724

Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Innovative Clinical Research Institute Whittier California 90603 United States Details
Boca Raton Clinical Research Plantation Florida 33322 United States Details
Rush University Chicago Illinois 60612 United States Details
University of Maryland Baltimore Maryland 21201 United States Details
University of Texas Southwestern Dallas Texas 75390 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field